Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar : a randomized comparison / C. P. Thakur ... [et al.]
Thakur, C. P, Sinha, G. P, Pandey, A. K, Barat, D & Singh, R. K. (1994). Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar : a randomized comparison / C. P. Thakur ... [et al.]. http://www.who.int/iris/handle/10665/48669
Bulletin of the World Health Organization 1994 ; 72(6) : 931-936
MetadataShow full item record
Showing items related by title and MeSH subject.
Report of a WHO informal consultation on liposomal amphotericin B in the treatment of visceral leishmaniasis, Rome, Italy, 16 April 2005 World Health Organization (WHO/CDS/NTD/IDM/2007.4, 2007)
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries / J. D. Berman ... [et al.] Berman, J. D; Badaro, R; Thakur, C. P; Wasunna, K. M; Behbehani, K; Davidson, R; Kuzoe, F; Pang, L; Weerasuriya, K; Bryceson, A. D. M (1998)
Collaborative study for the establishment of the second international standard for amphotericin B / by Guy Rautmann1 and Arnold Daas World Health Organization. Biologicals Unit; WHO Expert Committee on Biological Standardization (2008 : Geneva, Switzerland) (WHO/BS/07.2073, 2007)